578
Views
11
CrossRef citations to date
0
Altmetric
Pharmacological Aspects

Bipolar depression: trial-based insights to guide patient care

Depresión bipolar: reflexiones basadas en ensayos para orientar el tratamiento del paciente

Dépression bipolaire: réflexion à partir d'études pour orienter la prise en charge du patient

, , &
Pages 181-192 | Published online: 01 Apr 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ross J. Baldessarini, Eduard Vieta, Joseph R. Calabrese, Mauricio Tohen & Charles L. Bowden. (2010) Bipolar Depression: Overview and Commentary. Harvard Review of Psychiatry 18:3, pages 143-157.
Read now
Jean-Michel Azorin & Arthur Kaladjian. (2009) An update on the treatment of bipolar depression. Expert Opinion on Pharmacotherapy 10:2, pages 161-172.
Read now

Articles from other publishers (9)

Awais Aftab, David E. Kemp, Stephen J. Ganocy, Martha Schinagle, Carla Conroy, Brittany Brownrigg, Nicole D'Arcangelo, Toyomi Goto, Nicole Woods, Mary Beth Serrano, Huiqin Han, Joseph R. Calabrese & Keming Gao. (2019) Double-blind, placebo-controlled trial of pioglitazone for bipolar depression. Journal of Affective Disorders 245, pages 957-964.
Crossref
David E. Kemp, Martha Schinagle, Keming Gao, Carla Conroy, Stephen J. Ganocy, Faramarz Ismail-Beigi & Joseph R. Calabrese. (2014) PPAR-γ Agonism as a Modulator of Mood: Proof-of-Concept for Pioglitazone in Bipolar Depression. CNS Drugs 28:6, pages 571-581.
Crossref
N. A. Tyuvina & V. N. Smirnova. (2014) Comparative Assessment of the Efficacy of Valdoxane (agomelatine) in Recurrent Depression and Bipolar Affective Disorder. Neuroscience and Behavioral Physiology 44:2, pages 187-194.
Crossref
David E Kemp, Keming Gao, Elizabeth B Fein, Philip K Chan, Carla Conroy, Sarah Obral, Stephen J Ganocy & Joseph R Calabrese. (2012) Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder. Bipolar Disorders 14:7, pages 780-789.
Crossref
Beth DeJongh. (2012) Lithium use in bipolar disorder: Summary of evidence for acute mania, acute depression, and maintenance treatment. Mental Health Clinician 2:1, pages 10-14.
Crossref
Louisa G Sylvia, Noreen A Reilly-Harrington, Andrew C Leon, Christine I Kansky, Terence A Ketter, Joseph R Calabrese, Michael E Thase, Charles L Bowden, Edward S Friedman, Michael J Ostacher, Dan V Iosifescu, Joanne Severe, Michelle Keyes & Andrew A Nierenberg. (2011) Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment – Moderate dose Use Study (LiTMUS) for bipolar disorder. Clinical Trials 9:1, pages 94-101.
Crossref
Eduard Vieta, Julie Locklear, Oliver Günther, Mattias Ekman, Carolin Miltenburger, Mary Lou Chatterton, Mikael Åström & Björn Paulsson. (2010) Treatment Options for Bipolar Depression. Journal of Clinical Psychopharmacology 30:5, pages 579-590.
Crossref
Lewis L. Judd & Pamela J. Schettler. 2010. Bipolar Disorder. Bipolar Disorder 17 30 .
Catherine Datto, Lovisa Berggren, Jitendra B. Patel & Hans Eriksson. (2009) Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: A randomized, double-blind, crossover study in healthy adult subjects. Clinical Therapeutics 31:3, pages 492-502.
Crossref